4//SEC Filing
Sperzel John J III 4
Accession 0000950170-24-021248
CIK 0001492674other
Filed
Feb 26, 7:00 PM ET
Accepted
Feb 27, 4:31 PM ET
Size
6.7 KB
Accession
0000950170-24-021248
Insider Transaction Report
Form 4
Sperzel John J III
DirectorSee Remarks
Transactions
- Exercise/Conversion
Restricted Stock Units
2024-02-24−67→ 0 total→ Common Stock (67 underlying) - Exercise/Conversion
Common Stock
2024-02-24+67→ 400 total
Footnotes (2)
- [F1]Each restricted stock unit represents a contingent right to receive one share of the Issuer's common stock.
- [F2]On February 24, 2021 the reporting person was granted 200 RSU's that vest in three equal installments commencing on February 24, 2022.
Documents
Issuer
T2 Biosystems, Inc.
CIK 0001492674
Entity typeother
Related Parties
1- filerCIK 0001602618
Filing Metadata
- Form type
- 4
- Filed
- Feb 26, 7:00 PM ET
- Accepted
- Feb 27, 4:31 PM ET
- Size
- 6.7 KB